EcoR1 Capital, LLC 13D and 13G filings for Reata Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-09 5:47 pm Sale | 2022-12-31 | 13G | Reata Pharmaceuticals, Inc. RETA | EcoR1 Capital, LLC | 0 0.000% | -1,975,611 (Position Closed) | Filing |
| 2022-04-11 4:26 pm Purchase | 2022-03-31 | 13G | Reata Pharmaceuticals, Inc. RETA | EcoR1 Capital, LLC | 1,975,611 6.300% | 1,975,611 (New Position) | Filing |